GLP-1 medications were originally developed to treat type 2 diabetes, but their effects on appetite and blood sugar control have expanded their use to individuals across a wider weight spectrum
Retatrutide targets all three receptors (GLP-1, GIP, and glucagon) simultaneously, and Phase 2 data showed up to 24.2% weight loss at 48 weeks
However, significant challenges persist, notably navigating diverse global regulatory landscapes concerning glutathione classification and permitted health claims, alongside managing consumer expectations for rapid visible results
By wrapping the glutathione in tiny spheres of healthy fats called liposomes, we allow the supplement to survive the "gastric gauntlet." This delivery method mimics the bodys own cell membranes, which may support better uptake and utilization
The safest option depends on your hair type and the level of thinning
doi: 10.1095/biolreprod.102.003822, 138